Express Scripts Comments on FTC's Reckless Insulin Action

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action ST. LOUIS, Sept. 20, 2024 /PRNewswire/ -- Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today issued the...